English 
Spanish 
December 4, 2025
Shingles Vaccination: Dementia Impact | HPV Vaccine Dosage | COVID: Active Vaccination | COVID: The Late Phase/PASC/Long COVID
November 27, 2025
HPV | Polio | Influenza | RSV | COVID: Active Vaccination | COVID: The Late Phase/PASC/Long COVID
November 22, 2025
RSV | COVID: Active Vaccination/Immunity | COVID: Transmission | COVID: The Late Phase/PASC/Long COVID
November 7, 2025
SARS-CoV-2 | HPV Vaccination | Bird Flu | COVID: Active Vaccination/Immunity | COVID: Early Viral Stage | COVID: The Late Phase/PASC/Long COVID
The Impact of This Week in Parasitism on the Public Understanding of Science
Found under the ‘Resources’ tab of our website, the course was developed by Parasites Without Borders in conjunction with a team of fellows and medical educators at Columbia University Irving Medical Center and was revised by a panel of expert clinicians and researchers from all around the world.
The Impact of This Week in Parasitism on the Public Understanding of Science Read More »
October 30, 2025
SARS-CoV-2 mRNA Vaccination: Cancer Benefit | Viral Infection and Cardiovascular Disease | RSV: Revaccination | COVID: Active Vaccination/Immunity
October 23, 2025
Measles Without Rash During Acute Febrile Illness Surveillance in Tanzania, 2023-2024 | Susceptibility of Measles Virus to WHO Hand Rubs, Oral and Surface Disinfectants | Estimated Vaccine Effectiveness for Respiratory Syncytial Virus–Related Acute Respiratory Illness in Older Adults: Findings From the First Postlicensure Season
October 15, 2025
Effectiveness of NVX-CoV2373 and BNT162b2 COVID-19 Vaccination in South Korean Adolescents | Antiviral Efficacy of Oral Ensitrelvir versus Oral Ritonavir-boosted Nirmatrelvir in COVID-19 (PLATCOV): An Open-label, Phase 2, Randomised, Controlled, Adaptive Trial | Longitudinal Patient-reported Outcome Trajectories in Long COVID: Findings from the STOP-PASC Clinical Trial
October 11, 2025
Comparison of 2 Doses vs 1 Dose in the First Season Children Are Vaccinated Against Influenza: A Systematic Review and Meta-Analysis | Neonatal Outcomes Among Pregnant Women with COVID-19: A Systematic Scoping Review and Meta-analysis | Safety and Efficacy of Pemivibart, a Long-Acting Monoclonal Antibody, for Prevention of Symptomatic COVID-19: Interim Results From a Phase 3 Randomized Clinical Trial (CANOPY)
